Greenwich LifeSciences, Inc. (GLSI) DCF Valuation

Greenwich LifeSciences, Inc. (GLSI) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Greenwich LifeSciences, Inc. (GLSI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Greenwich LifeSciences, Inc. (GLSI) valuation analysis with our sophisticated DCF Calculator! Preloaded with real GLSI data, this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of Greenwich LifeSciences, Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -3.4 -1.9 -4.6 -8.0 -9.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.4 -1.9 -4.6 -8.0 -9.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 28.7 27.2 13.5 7.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 .3 .2 .2 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -3.4 -1.9 -4.6 -7.8 -9.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.8 -2.2 -4.6 -7.8 -9.5 .0 .0 .0 .0 .0
WACC, % 20.11 20.11 20.11 20.11 20.11 20.11 20.11 20.11 20.11 20.11
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -7
Equity Value 7
Diluted Shares Outstanding, MM 13
Equity Value Per Share 0.54

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financials for Greenwich LifeSciences, Inc. (GLSI).
  • Accurate Data: Historical performance data and forward-looking projections (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC as needed.
  • Instant Calculations: Quickly observe how your inputs influence the valuation of Greenwich LifeSciences, Inc. (GLSI).
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Layout: Organized for simplicity and ease of navigation, complete with step-by-step guidance.

Key Features

  • Comprehensive Data: Greenwich LifeSciences' historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Watch the intrinsic value of Greenwich LifeSciences (GLSI) update instantly.
  • Intuitive Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based GLSI DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Greenwich LifeSciences’ intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.

Why Choose This Calculator for Greenwich LifeSciences, Inc. (GLSI)?

  • Designed for Experts: A sophisticated tool tailored for researchers, financial analysts, and investment professionals.
  • Comprehensive Data: Greenwich LifeSciences' historical and anticipated financials included for precise analysis.
  • Flexible Scenario Analysis: Effortlessly model various projections and hypotheses.
  • Clear Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Detailed step-by-step guidance ensures a smooth experience.

Who Should Use This Product?

  • Investors: Make informed decisions with a cutting-edge valuation tool tailored for Greenwich LifeSciences, Inc. (GLSI).
  • Financial Analysts: Streamline your analysis with a ready-to-customize DCF model specific to the biotech sector.
  • Consultants: Efficiently modify the template for impactful client presentations or detailed reports on GLSI.
  • Biotech Enthusiasts: Enhance your knowledge of valuation methodologies using practical examples from Greenwich LifeSciences, Inc. (GLSI).
  • Educators and Students: Utilize it as a hands-on resource for finance and investment courses focused on the biotech industry.

What the Template Contains

  • Historical Data: Includes Greenwich LifeSciences, Inc. (GLSI)’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Greenwich LifeSciences, Inc. (GLSI)’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Greenwich LifeSciences, Inc. (GLSI)’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.